carbamazepine has been researched along with Parkinson Disease in 13 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The phenytoin treatment causes cerebellar defect and anemia." | 2.82 | The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches. ( Agrawal, M; Dhurandhar, Y; Panda, SP, 2022) |
| "Some comorbidities [e." | 1.48 | A systematic approach for identifying shared mechanisms in epilepsy and its comorbidities. ( Balzer, N; Domingo-Fernández, D; Güldenpfennig, A; Hofmann-Apitius, M; Hoyt, CT, 2018) |
| "We identified 8549 patients with Parkinson's disease using diagnosis criteria with a positive predictive value of 90%." | 1.39 | The association between Parkinson's disease and anti-epilepsy drug carbamazepine: a case-control study using the UK General Practice Research Database. ( Douglas, I; Skow, A; Smeeth, L, 2013) |
| "A treatment with carbamazepine was started and proved to be successful." | 1.39 | Complex visual hallucinations in a Parkinson patient: don't blame James if it's Charles's fault. ( Segers, K, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Panda, SP | 1 |
| Dhurandhar, Y | 1 |
| Agrawal, M | 1 |
| Hoyt, CT | 1 |
| Domingo-Fernández, D | 1 |
| Balzer, N | 1 |
| Güldenpfennig, A | 1 |
| Hofmann-Apitius, M | 1 |
| Skow, A | 1 |
| Douglas, I | 1 |
| Smeeth, L | 1 |
| Bach, JP | 1 |
| Oertel, WH | 1 |
| Dodel, R | 1 |
| Jessen, F | 1 |
| Saleh, C | 1 |
| Xiong, N | 1 |
| Jia, M | 1 |
| Chen, C | 1 |
| Xiong, J | 1 |
| Zhang, Z | 1 |
| Huang, J | 1 |
| Hou, L | 1 |
| Yang, H | 1 |
| Cao, X | 1 |
| Liang, Z | 1 |
| Sun, S | 1 |
| Lin, Z | 1 |
| Wang, T | 1 |
| Segers, K | 1 |
| Kovacs, N | 1 |
| Nagy, F | 1 |
| Balas, I | 1 |
| Komoly, S | 1 |
| Janszky, J | 1 |
| Stewart, JT | 1 |
| Yelton, JA | 1 |
| Gehlen, W | 1 |
| Clarke, BM | 1 |
| Upton, A | 1 |
| Griffin, H | 1 |
| Hudoba, P | 1 |
| Tyler, HR | 1 |
| Udvarhelyi, GB | 1 |
| Aronson, NI | 1 |
4 reviews available for carbamazepine and Parkinson Disease
| Article | Year |
|---|---|
The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches.
Topics: Anticonvulsants; Carbamazepine; Dementia; Epilepsy; Felbamate; Gabapentin; Humans; Inflammasomes; La | 2022 |
[Iatrogenic damage possibilities in the drug therapy of neurologic and psychiatric diseases].
Topics: Amantadine; Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Central Nervous System Di | 1977 |
Advances in neurology.
Topics: Analgesics; Anticoagulants; Brain; Brain Neoplasms; Carbamazepine; Cerebrovascular Disorders; Contra | 1968 |
Pain and motor disorders.
Topics: Basal Ganglia; Carbamazepine; Cordotomy; Electromyography; Evoked Potentials; Extrapyramidal Tracts; | 1969 |
9 other studies available for carbamazepine and Parkinson Disease
| Article | Year |
|---|---|
A systematic approach for identifying shared mechanisms in epilepsy and its comorbidities.
Topics: Alzheimer Disease; Carbamazepine; Comorbidity; Data Mining; Databases, Bibliographic; Databases, Gen | 2018 |
The association between Parkinson's disease and anti-epilepsy drug carbamazepine: a case-control study using the UK General Practice Research Database.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Case-Control Studies; Databases, Factual; D | 2013 |
Treatment of hypersexuality in Parkinson's disease with carbamazepine--a case report.
Topics: Aged, 80 and over; Analgesics, Non-Narcotic; Carbamazepine; Disruptive, Impulse Control, and Conduct | 2009 |
How to treat DBS-induced mania?
Topics: Aged; Bipolar Disorder; Carbamazepine; Clozapine; Deep Brain Stimulation; Female; Humans; Male; Midd | 2011 |
Potential autophagy enhancers attenuate rotenone-induced toxicity in SH-SY5Y.
Topics: Apoptosis; Autophagy; Blotting, Western; Carbamazepine; Cell Line, Tumor; Cell Survival; DNA Fragmen | 2011 |
Complex visual hallucinations in a Parkinson patient: don't blame James if it's Charles's fault.
Topics: Aged, 80 and over; Anticonvulsants; Carbamazepine; Diagnosis, Differential; Hallucinations; Humans; | 2013 |
Oxcarbazepine may induce psychotic symptoms in Parkinson's disease.
Topics: Aged; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Male; Oxcarbazepine; Parkinson Disease; Psyc | 2008 |
Treatment of organic hallucinosis with carbamazepine.
Topics: Aged; Aged, 80 and over; Carbamazepine; Female; Hallucinations; Humans; Parkinson Disease | 1995 |
Balance and cognitive impairment in two epileptic patients before and after vagal nerve stimulation.
Topics: Adult; Carbamazepine; Cognition; Electric Stimulation Therapy; Epilepsy, Temporal Lobe; Humans; Male | 1991 |